Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2025 22
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
A Phase III Randomized, Double-Blind, Active-Controlled, Multicenter Study on the Efficacy and Safety of Ezetimibe/Atorvastatin/Amlodipine Combination in Patients With Comorbid Primary Hypercholesterolemia and Essential Hypertension.
Lee CJ, Choi JY, Han SH, Shin J, Choi JH, Kim EJ, Choi JO, Sung JH, Kim KH, Lee PH, Hwang BH, Yoon YW, Kang SM. Lee CJ, et al. Clin Ther. 2025 Jun;47(6):436-444. doi: 10.1016/j.clinthera.2025.03.001. Epub 2025 Mar 22. Clin Ther. 2025. PMID: 40122716 Free article. Clinical Trial.
Lipid-Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-Blind, Parallel, Multicenter, Phase 3 Clinical Trial.
Ki YJ, Kim W, Lee KH, Han SJ, Kim YH, Doh JH, Kim TN, Chung CH, Kim DY, Cho JM, Yoon HJ, Jeong IK, Park S, Song KH, Yu CW, Cho DK, Choi SH, Oh SJ, Shin S, Jeong H, Park Y, Kim HS. Ki YJ, et al. Clin Cardiol. 2025 May;48(5):e70138. doi: 10.1002/clc.70138. Clin Cardiol. 2025. PMID: 40357888 Free PMC article. Clinical Trial.
Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial.
Hong SJ, Kim JH, Cha KS, Lee JB, Moon JY, Cho GY, Cho DK, Park JP, Yi JE, Kim KH, Jeong H, Rhee MY, Lee JH, Ahn KT, Yoon YW, Lee SY, Sung KC, Cha TJ, Shin J, Cho YH, Son JW, Ahn JH, Park SD, Kang WC, Hahn JY, Ha JW. Hong SJ, et al. Clin Ther. 2025 Nov;47(11):1028-1036. doi: 10.1016/j.clinthera.2025.08.012. Epub 2025 Sep 14. Clin Ther. 2025. PMID: 40947318 Free article. Clinical Trial.
Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial.
Ji X, Xia J, Zhang H, Ren C, Ma G, Fu S, Zhang J, Chen Y, Han X, Zhang J, Fang Z, Yang B, Yang B, Huang W, Yin G, Qi H, Gong H, Wang D, Hao L, Zhao X, Pei Z, Wang P, Li X, Lin L, Li D, Li Z, Zhang L, Yin B, Cheng Y, You Z, Sheng J, Wu J, Chen L, Fan Z, Zhao W, Zhao S. Ji X, et al. Lipids Health Dis. 2025 Jul 22;24(1):249. doi: 10.1186/s12944-025-02670-y. Lipids Health Dis. 2025. PMID: 40696391 Free PMC article. Clinical Trial.
22 results